Cargando…

Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review

OBJECTIVE: To explore the effect of topical cannabidiol (CBD) in treating digital ulcers in patients with systemic sclerosis (SSc). METHODS: In total, 45 patients with SSc who had digital ulcers were consecutively enrolled between January 2019 and December 2019. Of the participants, 25 were treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinella, Amelia, de Pinto, Marco, Baraldi, Carlo, Galluzzo, Claudio, Testoni, Sofia, Lumetti, Federica, Parenti, Luca, Guerzoni, Simona, Salvarani, Carlo, Giuggioli, Dilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788924/ https://www.ncbi.nlm.nih.gov/pubmed/36537770 http://dx.doi.org/10.1097/01.ASW.0000891856.08360.61

Ejemplares similares

Infections of scleroderma digital ulcers: A single center cohort retrospective study
por: Giuggioli, Dilia, et al.
Publicado: (2021)

Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers
por: Spinella, Amelia, et al.
Publicado: (2022)

Autologous fat grafting in the treatment of a scleroderma stump-skin ulcer: a case report
por: Giuggioli, Dilia, et al.
Publicado: (2021)

From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution
por: Dilia, Giuggioli, et al.
Publicado: (2018)

Erratum to “From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution”
por: Giuggioli, Dilia, et al.
Publicado: (2018)

Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers
por: Starnoni, Marta, et al.
Publicado: (2021)

One‐year clinical experience on the use of Nintedanib in systemic sclerosis
por: Magnani, Luca, et al.
Publicado: (2023)

Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis
por: Giuggioli, Dilia, et al.
Publicado: (2019)

Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center
por: Spinella, Amelia, et al.
Publicado: (2021)

Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature
por: Magnani, Luca, et al.
Publicado: (2023)

Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study
por: Isca, Chrystel, et al.
Publicado: (2022)

Elevated Troponin Serum Levels in Adult Onset Still's Disease
por: Manzini, Carlo Umberto, et al.
Publicado: (2015)

Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study
por: Toss, Angela, et al.
Publicado: (2021)

Divalproex sodium: A potential therapy for scleroderma digital ulcers
por: Urban, Jennifer R., et al.
Publicado: (2015)

Beyond Cat Scratch Disease: A Case Report of Bartonella Infection Mimicking Vasculitic Disorder
por: Spinella, Amelia, et al.
Publicado: (2012)

A glance into the future of myositis therapy
por: Chiapparoli, Ilaria, et al.
Publicado: (2022)

Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
por: Guerzoni, Simona, et al.
Publicado: (2016)

Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
por: Lo Castro, Flavia, et al.
Publicado: (2022)

Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial
por: Umpreecha, Chalapinyo, et al.
Publicado: (2023)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023)

Effects of Polyurethane Foam Dressings as an Add-on Therapy in the Management of Digital Ulcers in Scleroderma Patients
por: Rossi, FW, et al.
Publicado: (2020)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Predictors of response to erenumab after 12 months of treatment
por: Baraldi, Carlo, et al.
Publicado: (2021)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology
por: De Angelis, Rossella, et al.
Publicado: (2023)

PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers: Current Status of Clinical Trials
por: Impens, Ann J., et al.
Publicado: (2011)

Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study
por: Giuggioli, Dilia, et al.
Publicado: (2022)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
por: Naert, Alix, et al.
Publicado: (2013)

Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines
por: Ferri, Clodoveo, et al.
Publicado: (2012)

Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study
por: Stefani, Alessandro, et al.
Publicado: (2020)

Digital Ischemia in Scleroderma Spectrum of Diseases
por: Schiopu, Elena, et al.
Publicado: (2010)

Digital gangrene in a woman with scleroderma
por: Chatterjee, Soumya
Publicado: (2022)

Occlusal splint therapy in patients with Ménière’s disease and temporomandibular joint disorder
por: Monzani, Daniele, et al.
Publicado: (2022)

Scleroderma
Publicado: (1890)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
por: Macklin, Michael, et al.
Publicado: (2023)

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
por: Ornello, Raffaele, et al.
Publicado: (2020)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jj8i3petnh4ig2uha02p5nbaes